4 results match your criteria: "Non Clinical Development Department[Affiliation]"
Eur J Drug Metab Pharmacokinet
December 2020
Clinical Pharmacokinetics Department, POXEL SA, Lyon, France.
Unlabelled: BACKGROUND AND OBJECTIVE: Imeglimin is a novel oral antidiabetic drug to treat type 2 diabetes, targeting the mitochondrial bioenergetics. In vitro, imeglimin was shown to be a substrate of human multidrug and toxic extrusion transporters MATE1 and MATE2-K and organic cation transporters OCT1 and OCT2. The objective of the study was to assess the potential drug-drug interaction between imeglimin and cimetidine, a reference inhibitor of these transporters.
View Article and Find Full Text PDFBiopharm Drug Dispos
April 2017
Non-Clinical Development Department, UCB Biopharma sprl, Braine-l'Alleud, Belgium.
The dissolution, intestinal absorption and presystemic metabolism of a drug depend on its physicochemical characteristics but also on numerous physiological (e.g. gastrointestinal pH, volume, transit time, morphology) and biochemical factors (e.
View Article and Find Full Text PDFAnal Bioanal Chem
January 2012
Non Clinical Development Department, UCB Pharma SA, Braine L'Alleud, Belgium.
In nonclinical drug development targeting the central nervous system (CNS), the quantitative determination of extracellular brain concentrations of neurotransmitters is a key challenge. In some CNS disorders, the monitoring of the modified profile of neurotransmitter release such as that of histamine may explain the mechanism of action of the drug candidate. Microdialysis is a commonly used method for sampling extracellular levels of neurotransmitters/drug candidates in small laboratory animals.
View Article and Find Full Text PDFFundam Clin Pharmacol
February 2008
Non Clinical Development Department, UCB Pharma S.A., 21 rue de Neuilly, 92000 Nanterre, France.
Competition for uptake and/or efflux transporters can be responsible for drug interactions. Cetirizine is mainly eliminated unchanged in urine through both glomerular filtration and tubular secretion. The aim of this study was to investigate whether the eutomer, levocetirizine, and the distomer, dextrocetirizine, have a similar tubular secretion.
View Article and Find Full Text PDF